Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study

被引:9
作者
Beekmann, S. E. [1 ]
Diekema, D. J.
Heilmann, K. P.
Richter, S. S.
Doern, G. V.
机构
[1] Univ Iowa, Dept Pathol 265 MRC, Div Med Microbiol, Iowa City, IA 52242 USA
[2] Roy J & Lucille A Carver Univ Iowa, Coll Med, Dept Internal Med, Div Infect Dis, Iowa City, IA USA
关键词
Streptococcus pneumoniae; macrolide resistance; case-control study;
D O I
10.1007/s10096-006-0137-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of the case-control study presented here was to examine the risk factors for macrolide-resistant Streptococcus pneumoniae. As part of a 44-center U.S. surveillance study, 1,817 unique isolates of S. pneumoniae were collected from November 2002 through April 2003. Seventy-five randomly selected macrolide-resistant isolates (cases) were each matched with one susceptible control. Macrolide use in the 6 weeks prior to sample collection was reported for seven cases and one control. The final conditional logistic regression model identified two statistically significant variables: a history of alcohol abuse was protective, while macrolide use in the 6 weeks prior to sample collection was a significant risk factor for macrolide-resistant S. pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 14 条
[1]  
Barkai G, 2005, EMERG INFECT DIS, V11, P829
[2]   Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study [J].
ClavoSanchez, AJ ;
GironGonzalez, JA ;
LopezPrieto, D ;
CanuetoQuintero, J ;
SanchezPorto, A ;
VergaraCampos, A ;
MarinCasanova, P ;
CordobaDona, JA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1052-1059
[3]   Antimicrobial resistance among Streptococcus pneumoniae in the United States:: Have we begun to turn the corner on resistance to certain antimicrobial classes? [J].
Doern, GV ;
Richter, SS ;
Miller, A ;
Miller, N ;
Rice, C ;
Heilmann, K ;
Beekmann, S .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) :139-148
[4]   Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States [J].
Doern, GV .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S187-S192
[5]  
Edelstein PH, 2002, CLIN INFECT DIS, V34, P1418, DOI 10.1086/339943
[6]   Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae [J].
García-Rey, C ;
Aguilar, L ;
Baquero, F ;
Casal, J ;
Dal-Ré, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) :159-164
[7]   Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review [J].
Harris, AD ;
Karchmer, TB ;
Carmeli, Y ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) :1055-1061
[8]   Influence of macrolide antibiotics on promotion of resistance in the oral flora of children [J].
Kastner, U ;
Guggenbichler, JP .
INFECTION, 2001, 29 (05) :251-256
[9]   Reference group choice and antibiotic resistance outcomes [J].
Kaye, KS ;
Engemann, JJ ;
Mozaffari, E ;
Carmeli, Y .
EMERGING INFECTIOUS DISEASES, 2004, 10 (06) :1125-1128
[10]   Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia [J].
Kim, BN ;
Bae, IG ;
Kim, MN ;
Park, SJ ;
Woo, JH ;
Ryu, J ;
Kim, YS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (01) :35-42